Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019)

Relmada Therapeutics' (RLMD) quarterly Amortizatization of Intangibles came in at $1.0 in Q2 2019, down 100.0% year-on-year from $527980.0 in Q2 2018, and down 100.0% on a QoQ basis from $124647.0 in Q4 2018.

Relmada Therapeutics (RLMD) Amortizatization of Intangibles (2014 - 2019) Analysis & Trends

Relmada Therapeutics (RLMD) has 4 years of Amortizatization of Intangibles data on file, last reported at $1.0 in Q2 2019.

  • On a quarterly basis, Amortizatization of Intangibles fell 100.0% year-over-year to $1.0 in Q2 2019; TTM through Jun 2019 was $661168.0, a 35.76% decrease from a year earlier, with the FY2019 full-year figure at $661168.0, down 35.76% from the prior year.
  • Amortizatization of Intangibles for Q2 2019 stood at $1.0, down from $124647.0 in the prior quarter.
  • Over the last five years, Amortizatization of Intangibles for RLMD reached as high as $536520.0 in Q3 2018 and fell as low as $1.0 in Q2 2019.
  • Historically, Amortizatization of Intangibles has averaged $241478.7 across 3 years, with a median of $204962.0 in 2017.
  • Across the five-year window, Amortizatization of Intangibles surged 18932.28% in 2018 and plunged 100.0% in 2019, its largest moves.
  • Year by year, Amortizatization of Intangibles stood at $204962.0 in 2017, then sank by 39.19% to $124647.0 in 2018, then plunged by 100.0% to $1.0 in 2019.
  • Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $1.0 in Q2 2019, $124647.0 in Q4 2018, and $536520.0 in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Relmada Therapeutics 452.90 Mn 452.90 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2019 1.00
Jun 30, 2019 1.00
Dec 31, 2018 124,647.00
Dec 31, 2018 124,647.00
Sep 30, 2018 536,520.00
Sep 30, 2018 536,520.00
Jun 30, 2018 527,980.00
Jun 30, 2018 527,980.00
Mar 31, 2018 293,422.00
Mar 31, 2018 293,422.00
Dec 31, 2017 204,962.00
Dec 31, 2017 204,962.00
Sep 30, 2017 2,819.00
Sep 30, 2017 2,819.00
Jun 30, 2014 327,776.00
Jun 30, 2014 327,776.00
Mar 31, 2014 172,818.00
Mar 31, 2014 172,818.00